CSEIX | JABGX | CSEIX / JABGX | |
Total Expense Ratio | 1.10 | 0.91 | 121% |
Annual Report Gross Expense Ratio | 1.10 | 0.92 | 120% |
Fund Existence | 28 years | 5 years | - |
Gain YTD | 4.263 | -0.324 | -1,316% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 216M | 3,867% |
Annual Yield % from dividends | 2.72 | 1.91 | 143% |
Returns for 1 year | -1.84 | -2.17 | 85% |
Returns for 3 years | 32.55 | 19.32 | 169% |
Returns for 5 years | 27.20 | N/A | - |
Returns for 10 years | 55.25 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICGX | 67.75 | 0.36 | +0.53% |
American Funds Invmt Co of Amer R6 | |||
BRWTX | 29.14 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
NPSGX | 18.26 | N/A | N/A |
Nicholas Partners Small Cap Gr Instl | |||
JGYCX | 13.48 | N/A | N/A |
JHancock Global Shareholder Yield C | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C |